Report for Black SE

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (17)

Title : Soluble Epoxide Hydrolase Derived Linoleic Acid Oxylipins, Small Vessel Disease Markers, and Neurodegeneration in Stroke - Yu_2023_J.Am.Heart.Assoc_12_e026901
Author(s) : Yu D , Liang N , Zebarth J , Shen Q , Ozzoude M , Goubran M , Rabin JS , Ramirez J , Scott CJM , Gao F , Bartha R , Symons S , Haddad SMH , Berezuk C , Tan B , Kwan D , Hegele RA , Dilliott AA , Nanayakkara ND , Binns MA , Beaton D , Arnott SR , Lawrence-Dewar JM , Hassan A , Dowlatshahi D , Mandzia J , Sahlas D , Casaubon L , Saposnik G , Otoki Y , Lanctot KL , Masellis M , Black SE , Swartz RH , Taha AY , Swardfager W
Ref : J Am Heart Assoc , 12 :e026901 , 2023
Abstract : Yu_2023_J.Am.Heart.Assoc_12_e026901
ESTHER : Yu_2023_J.Am.Heart.Assoc_12_e026901
PubMedSearch : Yu_2023_J.Am.Heart.Assoc_12_e026901
PubMedID: 36583428

Title : Gantenerumab: an anti-amyloid monoclonal antibody with potential disease-modifying effects in early Alzheimer's disease - Bateman_2022_Alzheimers.Res.Ther_14_178
Author(s) : Bateman RJ , Cummings J , Schobel S , Salloway S , Vellas B , Boada M , Black SE , Blennow K , Fontoura P , Klein G , Assuncao SS , Smith J , Doody RS
Ref : Alzheimers Res Ther , 14 :178 , 2022
Abstract : Bateman_2022_Alzheimers.Res.Ther_14_178
ESTHER : Bateman_2022_Alzheimers.Res.Ther_14_178
PubMedSearch : Bateman_2022_Alzheimers.Res.Ther_14_178
PubMedID: 36447240

Title : Canadian Consensus Conference on Diagnosis and Treatment of Dementia (CCCDTD)5: Guidelines for management of vascular cognitive impairment - Smith_2020_Alzheimers.Dement.(N.Y)_6_e12056
Author(s) : Smith EE , Barber P , Field TS , Ganesh A , Hachinski V , Hogan DB , Lanctt KL , Lindsay MP , Sharma M , Swartz RH , Ismail Z , Gauthier S , Black SE
Ref : Alzheimers Dement (N Y) , 6 :e12056 , 2020
Abstract : Smith_2020_Alzheimers.Dement.(N.Y)_6_e12056
ESTHER : Smith_2020_Alzheimers.Dement.(N.Y)_6_e12056
PubMedSearch : Smith_2020_Alzheimers.Dement.(N.Y)_6_e12056
PubMedID: 33209971

Title : Soluble Epoxide Hydrolase-Derived Linoleic Acid Oxylipins in Serum Are Associated with Periventricular White Matter Hyperintensities and Vascular Cognitive Impairment - Yu_2019_Transl.Stroke.Res_10_522
Author(s) : Yu D , Hennebelle M , Sahlas DJ , Ramirez J , Gao F , Masellis M , Cogo-Moreira H , Swartz RH , Herrmann N , Chan PC , Pettersen JA , Stuss DT , Black SE , Taha AY , Swardfager W
Ref : Transl Stroke Res , 10 :522 , 2019
Abstract : Yu_2019_Transl.Stroke.Res_10_522
ESTHER : Yu_2019_Transl.Stroke.Res_10_522
PubMedSearch : Yu_2019_Transl.Stroke.Res_10_522
PubMedID: 30443886

Title : Attenuation of functional hyperemia to visual stimulation in mild Alzheimer's disease and its sensitivity to cholinesterase inhibition - Janik_2016_Biochim.Biophys.Acta_1862_957
Author(s) : Janik R , Thomason LA , Chaudhary S , Dorr A , Scouten A , Schwindt G , Masellis M , Stanisz GJ , Black SE , Stefanovic B
Ref : Biochimica & Biophysica Acta , 1862 :957 , 2016
Abstract : Janik_2016_Biochim.Biophys.Acta_1862_957
ESTHER : Janik_2016_Biochim.Biophys.Acta_1862_957
PubMedSearch : Janik_2016_Biochim.Biophys.Acta_1862_957
PubMedID: 26521151

Title : Treatment effects in multiple cognitive domains in Alzheimer's disease: a two-year cohort study - Behl_2014_Alzheimers.Res.Ther_6_48
Author(s) : Behl P , Edwards JD , Kiss A , Lanctot KL , Streiner DL , Black SE , Stuss DT
Ref : Alzheimers Res Ther , 6 :48 , 2014
Abstract : Behl_2014_Alzheimers.Res.Ther_6_48
ESTHER : Behl_2014_Alzheimers.Res.Ther_6_48
PubMedSearch : Behl_2014_Alzheimers.Res.Ther_6_48
PubMedID: 25484926

Title : Hemodynamic effects of cholinesterase inhibition in mild Alzheimer's disease - Chaudhary_2013_J.Magn.Reson.Imaging_38_26
Author(s) : Chaudhary S , Scouten A , Schwindt G , Janik R , Lee W , Sled JG , Black SE , Stefanovic B
Ref : J Magn Reson Imaging , 38 :26 , 2013
Abstract : Chaudhary_2013_J.Magn.Reson.Imaging_38_26
ESTHER : Chaudhary_2013_J.Magn.Reson.Imaging_38_26
PubMedSearch : Chaudhary_2013_J.Magn.Reson.Imaging_38_26
PubMedID: 23239554

Title : Discontinuing cholinesterase inhibitors: results of a survey of Canadian dementia experts - Herrmann_2011_Int.Psychogeriatr_23_539
Author(s) : Herrmann N , Black SE , Li A , Lanctot KL
Ref : Int Psychogeriatr , 23 :539 , 2011
Abstract : Herrmann_2011_Int.Psychogeriatr_23_539
ESTHER : Herrmann_2011_Int.Psychogeriatr_23_539
PubMedSearch : Herrmann_2011_Int.Psychogeriatr_23_539
PubMedID: 20849673

Title : Vascular cognitive impairment: epidemiology, subtypes, diagnosis and management - Black_2011_J.R.Coll.Physicians.Edinb_41_49
Author(s) : Black SE
Ref : J R Coll Physicians Edinb , 41 :49 , 2011
Abstract : Black_2011_J.R.Coll.Physicians.Edinb_41_49
ESTHER : Black_2011_J.R.Coll.Physicians.Edinb_41_49
PubMedSearch : Black_2011_J.R.Coll.Physicians.Edinb_41_49
PubMedID: 21365068

Title : Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: the emerging pharmacogenetic story - Lam_2009_Hum.Genomics_4_91
Author(s) : Lam B , Hollingdrake E , Kennedy JL , Black SE , Masellis M
Ref : Hum Genomics , 4 :91 , 2009
Abstract : Lam_2009_Hum.Genomics_4_91
ESTHER : Lam_2009_Hum.Genomics_4_91
PubMedSearch : Lam_2009_Hum.Genomics_4_91
PubMedID: 20038497

Title : Donepezil treatment in severe Alzheimer's disease: a pooled analysis of three clinical trials - Winblad_2009_Curr.Med.Res.Opin_25_2577
Author(s) : Winblad B , Black SE , Homma A , Schwam EM , Moline M , Xu Y , Perdomo CA , Swartz J , Albert K
Ref : Curr Med Res Opin , 25 :2577 , 2009
Abstract : Winblad_2009_Curr.Med.Res.Opin_25_2577
ESTHER : Winblad_2009_Curr.Med.Res.Opin_25_2577
PubMedSearch : Winblad_2009_Curr.Med.Res.Opin_25_2577
PubMedID: 19735164

Title : The effect of cholinesterase inhibitors on decline in multiple functional domains in Alzheimer's disease: a two-year observational study in the Sunnybrook dementia cohort - Behl_2008_Int.Psychogeriatr_20_1141
Author(s) : Behl P , Lanctot KL , Streiner DL , Black SE
Ref : Int Psychogeriatr , 20 :1141 , 2008
Abstract : Behl_2008_Int.Psychogeriatr_20_1141
ESTHER : Behl_2008_Int.Psychogeriatr_20_1141
PubMedSearch : Behl_2008_Int.Psychogeriatr_20_1141
PubMedID: 18606043

Title : Strategic subcortical hyperintensities in cholinergic pathways and executive function decline in treated Alzheimer patients - Behl_2007_Arch.Neurol_64_266
Author(s) : Behl P , Bocti C , Swartz RH , Gao F , Sahlas DJ , Lanctot KL , Streiner DL , Black SE
Ref : Archives of Neurology , 64 :266 , 2007
Abstract : Behl_2007_Arch.Neurol_64_266
ESTHER : Behl_2007_Arch.Neurol_64_266
PubMedSearch : Behl_2007_Arch.Neurol_64_266
PubMedID: 17296844

Title : Cholinesterase inhibitors slow decline in executive functions, rather than memory, in Alzheimer's disease: a 1-year observational study in the Sunnybrook dementia cohort - Behl_2006_Curr.Alzheimer.Res_3_147
Author(s) : Behl P , Lanctot KL , Streiner DL , Guimont I , Black SE
Ref : Curr Alzheimer Res , 3 :147 , 2006
Abstract : Behl_2006_Curr.Alzheimer.Res_3_147
ESTHER : Behl_2006_Curr.Alzheimer.Res_3_147
PubMedSearch : Behl_2006_Curr.Alzheimer.Res_3_147
PubMedID: 16611015

Title : Donepezil in vascular dementia: combined analysis of two large-scale clinical trials - Roman_2005_Dement.Geriatr.Cogn.Disord_20_338
Author(s) : Roman GC , Wilkinson DG , Doody RS , Black SE , Salloway SP , Schindler RJ
Ref : Dementia & Geriatric Cognitive Disorders , 20 :338 , 2005
Abstract : Roman_2005_Dement.Geriatr.Cogn.Disord_20_338
ESTHER : Roman_2005_Dement.Geriatr.Cogn.Disord_20_338
PubMedSearch : Roman_2005_Dement.Geriatr.Cogn.Disord_20_338
PubMedID: 16192723

Title : Potential treatment effects of donepezil not detected in Alzheimer's disease clinical trials: a physician survey - Rockwood_2004_Int.J.Geriatr.Psychiatry_19_954
Author(s) : Rockwood K , Black SE , Robillard A , Lussier I
Ref : Int J Geriatr Psychiatry , 19 :954 , 2004
Abstract : Rockwood_2004_Int.J.Geriatr.Psychiatry_19_954
ESTHER : Rockwood_2004_Int.J.Geriatr.Psychiatry_19_954
PubMedSearch : Rockwood_2004_Int.J.Geriatr.Psychiatry_19_954
PubMedID: 15449367

Title : Cognition-enhancing drugs in dementia: a guide to the near future - van Reekum_1997_Can.J.Psychiatry_42_35S
Author(s) : van Reekum R , Black SE , Conn D , Clarke D
Ref : Can J Psychiatry , 42 :35S , 1997
Abstract : van Reekum_1997_Can.J.Psychiatry_42_35S
ESTHER : van Reekum_1997_Can.J.Psychiatry_42_35S
PubMedSearch : van Reekum_1997_Can.J.Psychiatry_42_35S
PubMedID: 9220128